DELAYED RELEASE CYSTEAMINE IN NEPHROPATHIC CYSTINOSIS PATIENTS AFTER RENAL TRANSPLANT: A SUBGROUP ANALYSIS

被引：0

作者：

Grimm, Paul ^{[1
]}

Langman, Craig ^{[2
]}

Cochat, Pierre ^{[3
]}

Morin, Denis ^{[4
]}

Cornelissen, Elizabeth ^{[5
]}

Deschenes, Georges ^{[6
]}

Elenberg, Ewa ^{[7
]}

Greenbaum, Larry ^{[8
]}

Niaudet, Patrick ^{[9
]}

Checani, Gregg ^{[10
]}

机构：

[1] Stanford Univ, Sch Med, Pediat Nephrol, Stanford, CA 94305 USA

[2] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA

[3] Univ Lyon, Pediat, Lyon, France

[4] Univ Montpellier, Pediat, F-34059 Montpellier, France

[5] Radboud Univ Nijmegen, Pediat Nephrol, Nijimegen, Netherlands

[6] Hop Robert Debre, Pediat, F-75019 Paris, France

[7] Baylor Coll Med, Pediat, Houston, TX 77030 USA

[8] Emory Univ, Pediat, Atlanta, GA 30322 USA

[9] Hop Necker Enfants Malad, Pediat Nephrol, Paris, France

[10] Raptor Pharmaceut, Med Affairs, Novato, CA USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

MP691

引用

页码：1569 / 1569

页数：1

共 50 条

[1] A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
van Stein, Christina
Klank, Sabrina
Grueneberg, Marianne
Ottolenghi, Chris
Grebe, Jurgen
Reunert, Janine
Harms, Erik
Marquardt, Thorsten
ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[2] A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
Christina van Stein
Sabrina Klank
Marianne Grüneberg
Chris Ottolenghi
Jürgen Grebe
Janine Reunert
Erik Harms
Thorsten Marquardt
Orphanet Journal of Rare Diseases, 16
[3] Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis")
Langman, Craig B. B.
ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
[4] Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
Craig B. Langman
Orphanet Journal of Rare Diseases, 18
[5] Improvement of Tubular Function in Infantile Nephropathic Cystinosis after Delayed Onset of Cysteamine Treatment
Wade, A. W.
Midgley, J. P.
PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1921 - 1922
[6] ATTENUATION BUT NOT PREVENTION OF RENAL FANCONI SYNDROME BY CYSTEAMINE IN NEPHROPATHIC CYSTINOSIS
ADAMSON, M
SCHNEIDER, JA
BERNARDINI, I
REZNIK, VM
ADELMAN, R
GAHL, W
PEDIATRIC RESEARCH, 1989, 25 (04) : A334 - A334
[7] FAILURE OF CYSTEAMINE TO PREVENT RENAL FANCONI SYNDROME IN NEPHROPATHIC CYSTINOSIS
REZNIK, VM
ADAMSON, M
BERNARDINI, I
ADELMAN, R
GAHL, W
SCHNEIDER, JA
CLINICAL RESEARCH, 1989, 37 (01): : A218 - A218
[8] Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
Naïm Bouazza
Jean-Marc Tréluyer
Chris Ottolenghi
Saik Urien
Georges Deschenes
Daniel Ricquier
Patrick Niaudet
Bernadette Chadefaux-Vekemans
Orphanet Journal of Rare Diseases, 6
[9] Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
Bouazza, Naim
Treluyer, Jean-Marc
Ottolenghi, Chris
Urien, Saik
Deschenes, Georges
Ricquier, Daniel
Niaudet, Patrick
Chadefaux-Vekemans, Bernadette
ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
[10] EFFECTS OF TRANSITIONING FROM IMMEDIATE RELEASE TO EXTENDED RELEASE CYSTEAMINE THERAPY IN NORWEGIAN PATIENTS WITH NEPHROPATHIC CYSTINOSIS
Aase, Sonja Amdal
Radtke, Maria
Siva, Christian
Vikse, Bjorn Egil
Brackman, Damien
Gudmundsdottir, Helga
Forsberg, Brita
Bjerre, Anna
PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2843 - 2843

← 1 2 3 4 5 →